Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

abcur ab - thiopentalum natricum inn - stungulyfsstofn, lausn - 1 g

Evrópusambandið - íslenska - EMA (European Medicines Agency)

glaxosmithkline trading services - flútíkasónfúróat, umeclidiniumbrómíð, vílanteróltrifenatat - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - trelegy ellipta er ætlað eins og viðhald í meðferð hjá fullorðnum með í meðallagi til alvarlega langvinn veikindi í lungum (llt) sem eru ekki nægilega meðhöndluð með sambland af andað barksteri og langverkandi β2-örva.

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vetviva richter gmbh - procainum hýdróklóríð - stungulyf, lausn - 20 mg/ml

Evrópusambandið - íslenska - EMA (European Medicines Agency)

glaxosmithkline trading services limited - flútíkasónfúróat, umeclidiniumbrómíð, vílanteróltrifenatat - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - elebrato ellipta er ætlað eins og viðhald í meðferð hjá fullorðnum með í meðallagi til alvarlega langvinn veikindi í lungum (llt) sem eru ekki nægilega meðhöndluð með sambland af andað barksteri og langverkandi β2-örva.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

eli lilly nederland b.v. - lasmiditan succinate - mígreni kvilla - verkjalyf - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

teva b.v. - salmeterol, flútikasón nef - pulmonary disease, chronic obstructive; asthma - lyf til veikindi öndunarvegi sjúkdómum, - airexar spiromax er ætlað til notkunar hjá fullorðnum 18 ára og eldri. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. langvinn veikindi í lungum (llt)airexar viðeigandi er ætlað til meðferð við sjúklinga með llt, með fev1.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozin própandiolól einhýdrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lyf notuð við sykursýki - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. auk þess önnur lyf fyrir meðferð tegund sykursýki 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozin própandiolól einhýdrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lyf notuð við sykursýki - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. auk þess önnur lyf fyrir meðferð tegund sykursýki 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

aziende chimiche riunite angelini francesco s.p.a. - lurasidón - geðklofa - psycholeptics - meðferð við geðklofa hjá fullorðnum 18 ára og eldri.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - sýklalyf fyrir almenn nota, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum. viðeigandi að nota af sýklalyfjum.